Tolmar Introduces Care Partner Corner: A New Resource for Prostate Cancer Caregivers Tolmar, Inc. has launched Care Partner Corner, a digital platform aimed at supporting caregivers of prostate cancer patients with essential resources.

Tolmar Introduces Care Partner Corner: A New Resource for Prostate Cancer Caregivers #US #Buffalo_Grove #Prostate_Cancer #Tolmar #Care_Partner

FDA Approves Rubraca® Expansion as Early Treatment for Prostate Cancer The FDA has granted expanded approval for Rubraca®, the first PARP inhibitor to outperform docetaxel, offering earlier treatment options for prostate cancer patients.

FDA Approves Rubraca® Expansion as Early Treatment for Prostate Cancer #USA #Buffalo_Grove #Tolmar #Rubraca #PARP_Inhibitor

Rosalind Franklin University Expands Innovation with Tolmar's New Lab in Illinois Rosalind Franklin University has welcomed Tolmar, Inc. to its Innovation and Research Park, enhancing pharmaceutical development opportunities in Illinois.

Rosalind Franklin University Expands Innovation with Tolmar's New Lab in Illinois #United_States #North_Chicago #Rosalind_Franklin #Tolmar #Pharmaceutical_Lab

My favorite #caricature at a #wowsers gig last weekend for #tolmar employee families at CSU’s Canvas Stadium.
#livecaricature

Climbing to Raise Prostate Cancer Awareness: A Bold New Initiative The Peaks Challenge, launched by ZERO Prostate Cancer and Tolmar, aims to raise awareness about survivorship and early detection of prostate cancer through a groundbreaking climbing expedition.

Climbing to Raise Prostate Cancer Awareness: A Bold New Initiative #United_States #Alexandria #ProstateCancer #PeaksChallenge #Tolmar